save your child's quakity of life and more
faustmanlab.org
uspyo.gov faustman dl inventor search
tslk to lee iaacoccs
jennifer kills children with immunity and impunity snd dupreme arrogsnce by failing to regrnerste cells in her type 1 disbetic patients
faustmanlab.org saves jennifer kills
when you kill and injure childre with an autoimmune disease by failing to modify their immune system with bcg or tnf alpha to allow indulin produving cells to regenerste you are committing murder as the complicstions from type 1 disbetes speed death malfunction duffering etc
bcg has been administered for years and is safe and effective
jennifer was tsught to kill in medical school by her failre to keep an open mind and read
death as an incidence to business occurs st stonybrook and other hospitsl gangs and do gooder organizations
Dr. Jennifer Osipoff meets with her Type 1 diabetes patient, 5-year-old Nadia McKee of East Setauket, at the Stony Brook Children's Hospital clinic in East Setauket on Thursday, June 29, 2017. Photo Credit: Daniel Goodrich
Managing diabetes in children is a round-the-clock enterprise that soon may become less worrisome for parents with the introduction of a device popularly called an artificial pancreas.
Formally known as the MiniMed 670G system, the device was developed by the Minnesota medical device company Medtronic, and was approved by the U.S. Food and Drug Administration last summer.
It is designed for people with Type 1 diabetes, the form of the disease in which the pancreas produces little or no insulin — the hormone that controls blood sugar, also known as glucose. Type 1 diabetics have to be provided with insulin either through daily injections or a conventional pump.
Unlike older devices, the new system functions as a pump and continuous glucose monitor, keeping blood sugar in a normal range via embedded electronic intelligence.
By automatically monitoring glucose every five minutes and correcting imbalances, the MiniMed system reduces the risk of life-threatening diabetic episodes. Parents of youngsters with Type 1 diabetes have long interrupted their children at night as they slept to test blood sugar, which naturally drops during slumber. Children using the device can safely sleep through the night.
Dr. Jennifer Osipoff and Type 1 diabetes patient Nadia McKee, 5, of East Setauket, play with Lenny the lion at the Stony Brook Children's Hospital clinic in East Setauket on Thursday, June 29, 2017. Photo Credit: Daniel Goodrich
“It is finally being rolled out to pediatric patients,” said Dr. Jennifer Osipoff, a pediatric endocrinologist at Stony Brook Children’s Hospital. “Adult patients started receiving it in the middle of April. But now, at long last, our pediatric patients will be receiving it as part of our priority access program.”
ADVERTISEMENT | ADVERTISE ON NEWSDAY
The system consists of a tiny sensor with an attached needle that is placed under the skin to continually monitor glucose. Another key component is the pump, usually worn near the abdomen. This portion has tubing to deliver insulin.
Osipoff calls it a closed-loop system because it is both a pump and a monitor. Some doctors — and numerous patients — call it an artificial pancreas because its level of sophistication mimics functions of the human organ.
Although the MiniMed system — estimated to cost between $6,000 and $8,000, not including expenses for the disposable sensors — was approved by the FDA for teens 14 and older, doctors are allowed to prescribe the device “off-label,” which in this instance means using it for age groups not included in regulators’ final approval.
Type 1 diabetes usually is diagnosed in childhood, hence its original name, juvenile diabetes.
“My youngest patient who is on a [conventional] insulin pump is 19 months old, and my youngest patient ever was 7 months old,” Osipoff said.
She said she will prescribe the device off-label because it is vital to effectively control blood sugar as early as possible in children with Type 1 diabetes. Elevated glucose can lead to organ damage, blindness and amputations. Blood sugar that is too low can trigger unconsciousness, Osipoff said.
Her first patient to soon start using the MiniMed system is 5-year-old Nadia McKee of East Setauket.
Nadia and her parents, Daniela and Robert McKee, attended a recent Technology Night sponsored by Stony Brook and JDRF, a juvenile diabetes foundation, which introduced families to the MiniMed system.
“Nadia will be starting it in about a week,” Daniela McKee said Friday. “In our conversations with the doctor, we’ve learned how it works and we are very excited about it because this machine means a longer and healthier life.
“What this will provide is the next step,” the mother said. “It will monitor her sugar itself, which is incredible.”
ADVERTISEMENT | ADVERTISE ON NEWSDAY
She said Nadia, though very young, understands the need for technology in her life and already has worn a conventional insulin pump.
“Children who are battling a chronic disease would surprise you with what they understand,” McKee said. “She understands, in a 5-year-old’s terms, that her pancreas doesn’t work and that we have to provide her with these machines to do what her body cannot.”
Robert McKee said he is not fazed by the off-label usage. “The pump she is on now is in the same [off-label] category,” he said. “That’s what the FDA does.”
He also is excited that his daughter, who starts kindergarten in the fall, is a medical pioneer.
“She is the first pediatric patient,” he said. “That’s why this is a big deal.”
Dr. Jennifer Osipoff meets with her Type 1 diabetes patient, 5-year-old Nadia McKee of East Setauket, at the Stony Brook Children's Hospital clinic in East Setauket on Thursday, June 29, 2017. (Credit: Daniel Goodrich)
Managing diabetes in children is a round-the-clock enterprise that soon may become less worrisome for parents with the introduction of a device popularly called an artificial pancreas.
Formally known as the MiniMed 670G system, the device was developed by the Minnesota medical device company Medtronic, and was approved by the U.S. Food and Drug Administration last summer.
It is designed...
injuries to the innocent under age 6 is grnerally held to be bad?
HILLSBORO, Ore., July 30— A man who prosecutors say was under orders from a top Hell's Angels leader was convicted today of murdering a woman, her twin 6-year-old girls and a family friend 17 years ago.
The defendant, Robert G. McClure, 47, was sentenced immediately after the verdict to four consecutive life terms in prison.
Mr. McClure had claimed that he had been framed by the bikers club. He sat impassively as the verdicts and sentences were read. His lawyer, Lisa Maxfield of Portland, said he would appeal.
The jury in Washington County Circuit Court deliberated more than six hours over two days before returning the unanimous verdicts.
Judge Jon B. Lund called the trial one of the "most egregious" murder cases he had ever heard. He told Mr. McClure that he had killed "four innocent people in a heartless and coldblooded fashion."
Execution-Style Killings
On Aug. 7, 1977, Margo Compton, 24, was found dead in her home in the rural town of Gaston, along with her daughters, Sylvia and Sandra, and Gary Seslar, 19, the son of her boyfriend. Each had been shot in the head.
Ms. Compton's sister, Lynne Spieckerman of Gonzales, Tex., burst into tears when the verdict was announced. She and Bonnie Sleeper, who was Mr. Seslar's fiancee and who discovered the bodies, both hugged the prosecutors, Robert Hamilton and Robert Heard.
"I believed in these guys," Ms. Spieckerman said. "They really knew what they were doing. When you kill children and innocent people, you just can't get away with it. You just can't get away with it."
Mr. Hamilton said, "I'm relieved because this has been a long, long journey and I'm appreciative to so many, starting with the jury."
The prosecutors contended that Mr. McClure had been under orders from Odis Garrett to kill Ms. Compton in retaliation for her testimony against several Hell's Angels in a San Francisco prostitution trial.
Both Mr. McClure and Mr. Garrett, a leader of the Oakland, Calif., chapter of the Hell's Angels, were later imprisoned on drug charges.
Facing Extradition
Mr. Garrett, who was also charged in the killings, is serving time in a California prison on a drug conviction but still faces extradition to Oregon. He was convicted in the San Francisco prostitution case after Ms. Compton testified against him.
Several prison inmates testified that the two had talked about their roles in the killings. The inmates said they had agreed to testify for the state because killing children violated their code of conduct.
One prisoner testified that Mr. McClure had bragged about making Ms. Compton watch as he shot her daughters first and had claimed that they had died clutching their teddy bears.
Mr. McClure, described as a hanger-on rather than a member of the biker club, maintained that he had been framed by the Hell's Angels because they wanted to protect the real killer. The defense claimed that the inmates who testified had done so to gain early release or better prison housing.
Security at the suburban courthouse, about 15 miles west of Portland, was extremely tight through the seven-week trial.
'Infamous Case'
More than 75 witnesses testified, including members of the Hell's Angels and the Aryan Brotherhood prison gang. Many were brought into the courtroom in leg irons, handcuffs and waist chains.
Lou Barbaria, a senior investigator with the New York State Police, has been following the trial from across the country. "It's an infamous case in the law-enforcement circuit," Mr. Barbaria said. He cited a Federal court case in New York in which the Hell's Angels involvement in the death of Ms. Compton had been admitted as proof of the club's viciousness toward those who testified against them.
No comments:
Post a Comment